Phenotypic and genetic characterization of patients with features of "nonclassic" forms of cystic fibrosis

被引:26
作者
Groman, JD
Karczeski, B
Sheridan, M
Robinson, TE
Fallin, MD
Cutting, GR
机构
[1] Johns Hopkins Univ, Sch Med, Inst Med Genet, Baltimore, MD 21287 USA
[2] Cyst Fibrosis Fdn, Genotyping Ctr, Baltimore, MD USA
[3] McKusick Nathans Inst Genet Med, Blooomberg Sch Publ Hlth, Baltimore, MD USA
[4] Stanford Univ, Med Ctr, Div Pediat Pulmonol, Palo Alto, CA 94304 USA
关键词
D O I
10.1016/j.jpeds.2004.12.020
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Objective To determine which features of incomplete or "nonclassic" forms of cystic fibrosis (CF) are associated with deleterious CF transmembrane conductance regulator gene (CFTR) mutations, and to explore other etiologies for features not associated with deleterious CFTR mutations. Study design Clinical features were compared between 57 patients with deleterious mutations in each CFTR and 63 with 110 deleterious Mutations. The Shwachman Bodian Diamond syndrome gene (SBDS) was sequenced to search for imitations in patients with no deleterious CFTR mutations and steatorrhea to determine if any had unrecognized Shwachman-Diamond syndrome (SDS). Results The presence of a common CF-causing Mutation, absence of the Vas deferens, and Pseudomona aeruginosa in the sputum correlated with the presence of two deleterious CFTR mutations, whereas sweat chloride concentration, diagnostic criteria for CF. and steatorrhea did not. However, sweat chloride concentration correlated with CFTR mutation status in patients infected with P aeruginosa. One patient had disease-causing mutations in each SBDS. Conclusions Presence of a common CF-causing mutation, absence of the vas deferens and/or P aeruginosa infection in a patient with features of nonclassic CF are predictive of deleterious imitations in each CFTR, whereas steatorrhea in the same, a p, context is likely to have etiologies other than CF transmembrane conductance regulator (CFTR) dysfunction.
引用
收藏
页码:675 / 680
页数:6
相关论文
共 18 条
[11]   Considerations for a multiaxis nomenclature system for medical genetics [J].
Robin, NH ;
Biesecker, LG .
GENETICS IN MEDICINE, 2001, 3 (04) :290-293
[12]   The diagnosis of cystic fibrosis: A consensus statement [J].
Rosenstein, BJ ;
Cutting, GR .
JOURNAL OF PEDIATRICS, 1998, 132 (04) :589-595
[13]   Nonclassic cystic fibrosis: A clinical conundrum [J].
Rosenstein, BJ .
PEDIATRIC PULMONOLOGY, 2003, 36 (01) :10-12
[14]  
Wallis C, 2003, J ROY SOC MED, V96, P2
[15]  
Welsh MJ., 2001, METABOLIC MOL BASES, V3, P5121, DOI DOI 10.1036/OMMBID.236
[16]   Nasal potential difference measurements in patients with atypical cystic fibrosis [J].
Wilschanski, M ;
Famini, H ;
Strauss-Liviatan, N ;
Rivlin, J ;
Blau, H ;
Bibi, H ;
Bentur, L ;
Yahav, Y ;
Springer, H ;
Kramer, MR ;
Klar, A ;
Ilani, A ;
Kerem, B ;
Kerem, E .
EUROPEAN RESPIRATORY JOURNAL, 2001, 17 (06) :1208-1215
[17]   Uncertainty in the diagnosis of cystic fibrosis: Possible role of in vivo nasal potential difference measurements [J].
Wilson, DC ;
Ellis, L ;
Zielenski, J ;
Corey, M ;
Ip, WF ;
Tsui, LC ;
Tullis, E ;
Knowles, MR ;
Durie, PR .
JOURNAL OF PEDIATRICS, 1998, 132 (04) :596-599
[18]   Comprehensive mutation screening in a cystic fibrosis center [J].
Wine, JJ ;
Kuo, E ;
Hurlock, G ;
Moss, RB .
PEDIATRICS, 2001, 107 (02) :280-286